Trial Profile
Pharmaco-epidemiological Study Describing the Hypertensive Population Treated With Telmisartan and Conditions of Use by Medical Practitioners and Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Sep 2014
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 24 Sep 2014 New trial record